CytomX Therapeutics Inc

15 set 2026, 23:51 UTC

CytomX Therapeutics Inc shares are higher in after-market hours, though no specific news explains the movement. This marks a shift from recent trends.

14 set 2026, 20:07 UTC

CytomX Therapeutics Inc shares are lower amid broader market weakness and rising crude oil prices, with no specific news identified to explain the decline.

11 set 2026, 20:08 UTC

CytomX Therapeutics Inc's shares are lower today, continuing a trend of four consecutive sessions with declines and trading below the 20-day moving average.

10 set 2026, 20:07 UTC

CytomX Therapeutics Inc shares declined during Thursday's session, continuing a downward trend with no specific news identified to explain the movement.

9 set 2026, 19:26 UTC

CytomX Therapeutics shares are lower during Wednesday's session, continuing a decline since Tuesday's close, amid broader market reactions to rising crude oil prices.

8 set 2026, 23:01 UTC

CytomX Therapeutics Inc shares are higher in after-market trading, maintaining a strong position above its 20-day moving average amid broader market trends.

4 set 2026, 20:07 UTC

CytomX Therapeutics Inc shares are higher during Friday's session, recovering from an earlier dip and remaining above the 20-day moving average.

2 set 2026, 20:08 UTC

CytomX Therapeutics shares are higher, supported by Piper Sandler's $12 price target and positive sentiment in the Biotechnology sector ahead of upcoming data releases.

1 set 2026, 20:01 UTC

CytomX Therapeutics is trading higher as it announces participation in key investor conferences and growing fund interest ahead of upcoming data releases.

31 ago 2026, 20:07 UTC

CytomX Therapeutics is trading higher, following broader market gains since Friday. No specific company news was identified to explain the increase.

28 ago 2026, 19:51 UTC

CytomX Therapeutics shares are lower despite FDA granting Fast Track Designation for Varseta-M to treat metastatic colorectal cancer. Trading volume is unusually high.

27 ago 2026, 23:02 UTC

CytomX Therapeutics received Fast Track Designation for Varseta-M, yet shares are trading lower in after-market hours, breaking a recent trend of gains.

25 ago 2026, 19:56 UTC

CytomX Therapeutics is trading higher amid positive market conditions and lower crude oil prices, which have decreased treasury yields and boosted investor sentiment.

24 ago 2026, 19:26 UTC

CytomX Therapeutics is trading higher, reflecting gains since Friday's close. Earlier, shares peaked with a gain before pulling back to a modest advance.

21 ago 2026, 19:46 UTC

CytomX Therapeutics Inc. is gaining during Friday's session, despite earlier volatility. No specific company news was identified to explain today's price movement.

20 ago 2026, 21:01 UTC

CytomX Therapeutics Inc shares are higher in after-market hours, reflecting unusual trading activity. The stock is positioned around the midpoint of its one-month range.

19 ago 2026, 20:02 UTC

CytomX Therapeutics is trading higher during Wednesday's session, continuing a strong upward move since Tuesday's close amid notable volatility.

14 ago 2026, 19:36 UTC

CytomX Therapeutics is higher as social media highlights its undervaluation, with a suggested price target of $6-7 ahead of year-end data releases.

13 ago 2026, 22:01 UTC

CytomX Therapeutics shares are higher in after-market trading, supported by broader market strength and a record closing high for the S&P 500.

12 ago 2026, 19:46 UTC

CytomX Therapeutics Inc shares are higher today, continuing an upward trend since Tuesday's close, supported by positive sentiment from the recent inflation report.

11 ago 2026, 23:21 UTC

CytomX Therapeutics Inc. shares are higher in after-market trading, reaching 1.45% above Tuesday's close amid strong performance relative to its moving average.

10 ago 2026, 23:31 UTC

CytomX Therapeutics Inc shares are lower in after-market hours after earlier volatility. Broader market sentiment remains cautious amid geopolitical tensions in the Strait of Hormuz.

7 ago 2026, 19:16 UTC

CytomX Therapeutics expands collaboration with Regeneron on immunotherapies and updates on Varseta-M program, boosting sentiment amid a rising Biotechnology sector.

6 ago 2026, 22:02 UTC

CytomX Therapeutics shares declined in after-market hours following a significant revenue miss of $1.418 million against expectations of $12.308 million.

31 lug 2026, 20:06 UTC

CytomX Therapeutics Inc shares declined sharply during Friday's session, reversing earlier gains and trading well below the 20-day moving average. No specific news was identified.

29 lug 2026, 19:47 UTC

CytomX Therapeutics shares are lower as traders await the Federal Reserve's interest rate decision, contributing to mixed performance across major U.S. indices.

28 lug 2026, 17:46 UTC

CytomX Therapeutics shares are lower today, reflecting a broader cautious tone across Asian markets. The stock remains near its one-month low.

27 lug 2026, 23:26 UTC

CytomX Therapeutics shares are higher in after-market hours, though no specific news was identified. Broader positive sentiment in European indices may be influencing investors.

21 lug 2026, 19:56 UTC

CytomX Therapeutics Inc shares are lower today, continuing a downward trend. The stock remains significantly below its 20-day moving average.